Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-24

Clinical Trial Update: Administration of L. Paracasei 28.4 as an Adjunct to the Treatment of Periodontitis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating L. paracasei 28.4 as an adjunct to standard treatment for periodontitis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L. paracasei 28.4 (Lactobacillus paracasei 28.4)

Snippet

Sponsor: Universidade Estadual Paulista Júlio de Mesquita Filho | Conditions: Periodontitis | Phase 1, Phase 2 | Status: UNKNOWN